Riastap (FIBRINOGEN HUMAN)

**Product type:** Plasma Derivative

**Active ingredient:** FIBRINOGEN HUMAN

**Strength:** 2600 mg/100mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** CSL Behring GmbH

**Marketing category:** BLA (BLA125317)

**Pharmacologic class:** Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE]